Home Multimedia Podcasts STEM CELL THERAPIES ON THE RISE STEM CELL THERAPIES ON THE RISE February 5, 2009 – Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN’s Editor in Chief, John Sterling /wp-content/uploads/2018/09/gc249_2_5_2009.mp3 PodcastsResourcesCell therapyClinical trialDrug research and developmentEmbryonic stem cellsGenetic engineeringGenetic Engineering and BiotechnologyMedicineMedicine, Diagnosis, and TherapeuticsPharmacologyPluripotent stem cellsRegenerative engineeringResearch and developmentResearch resourcesStem cell engineeringStem cellsTherapeuticsTranslational medicine Also of Interest Monoclonal Antibodies Are Paving the Way for Advanced Therapies New FDA Guidance Impacts the CAR-T Industry Robots and AI: The Future of Cell and Gene Therapy Manufacturing Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Related Media Sickle Cell Salvation: The Victoria Gray Interview Excitement in Oakland: A Report from SynBioBeta Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World Book Review: The Exceptions Related Content Monoclonal Antibodies Are Paving the Way for Advanced Therapies New FDA Guidance Impacts the CAR-T Industry Robots and AI: The Future of Cell and Gene Therapy Manufacturing Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform